Literature DB >> 13832087

Reserpine in weight reduction. The effect in obese patients on 1,000-calorie diets: a controlled study.

M C SMITH.   

Abstract

In a controlled study (the control group receiving pyribenzamine) it was observed that reserpine, in the dosage used, had no effect on weight loss in patients receiving d-amphetamine sulphate (Dexedrine(R)) and methyl cellulose (Cellothyl(R)) while on 1,000-calorie diets as compared with the control group. There was no observable difference in subjective feelings of the patients in the two groups. Reserpine had no effect on the length of time the patients remained on their diets.

Entities:  

Keywords:  OBESITY/therapy; RESERPINE/therapy

Mesh:

Substances:

Year:  1959        PMID: 13832087      PMCID: PMC1577779     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  7 in total

1.  Rauwolfia and amphetamine therapy in the treatment of psychosomatic complaints.

Authors:  P E PROUET
Journal:  J La State Med Soc       Date:  1955-03

2.  Balanced amphetamine and sedative combination in the treatment of obesity.

Authors:  H NECHELES; H SORTER
Journal:  J Lancet       Date:  1957-06

3.  A new drug in the management of obesity; a preliminary report.

Authors:  J D MCNAIR
Journal:  Am Pract Dig Treat       Date:  1955-11

4.  Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.

Authors:  S KINARD; L C MILLS; J H MOYER; J TERRELL
Journal:  J Am Geriatr Soc       Date:  1956-11       Impact factor: 5.562

5.  Management of the depressed patient.

Authors:  G J TRINITY
Journal:  Med Times       Date:  1954-10

6.  A psychobiologic approach to the problem of obesity.

Authors:  A D JONAS
Journal:  Am Pract Dig Treat       Date:  1950-09

7.  Reserpine (serpasil) in the treatment of hypertension.

Authors:  W HUGHES; E DENNIS; R McCONN; R FORD; J H MOYER
Journal:  Am J Med Sci       Date:  1954-07       Impact factor: 2.378

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.